.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Julphar
Dow
Cipla
Fuji
McKinsey
Federal Trade Commission
Teva
Moodys

Generated: June 24, 2017

DrugPatentWatch Database Preview

ACEPHEN Drug Profile

« Back to Dashboard

Which patents cover Acephen, and when can generic versions of Acephen launch?

Acephen is a drug marketed by G And W Labs and is included in four NDAs.

The generic ingredient in ACEPHEN is acetaminophen. There are sixty-five drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the acetaminophen profile page.

Summary for Tradename: ACEPHEN

Patents:0
Applicants:1
NDAs:4
Suppliers / Packagers: see list4
Bulk Api Vendors: see list98
Patent Applications: see list9,601
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ACEPHEN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
G And W Labs
ACEPHEN
acetaminophen
SUPPOSITORY;RECTAL072218-001Mar 27, 1992DISCNNoNo► Subscribe► Subscribe
G And W Labs
ACEPHEN
acetaminophen
SUPPOSITORY;RECTAL018060-001Approved Prior to Jan 1, 1982OTCNoNo► Subscribe► Subscribe
G And W Labs
ACEPHEN
acetaminophen
SUPPOSITORY;RECTAL072237-001Mar 27, 1992OTCNoNo► Subscribe► Subscribe
G And W Labs
ACEPHEN
acetaminophen
SUPPOSITORY;RECTAL072344-001Mar 27, 1992OTCNoNo► Subscribe► Subscribe
G And W Labs
ACEPHEN
acetaminophen
SUPPOSITORY;RECTAL018060-002Approved Prior to Jan 1, 1982OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Citi
Deloitte
Covington
McKesson
Daiichi Sankyo
Mallinckrodt
Queensland Health
Novartis
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot